Selenium Intervention Registry Randomized Trial in Heart Failure
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4326 participants.
Also called NCT07543562
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 4,326 participants
- Registry
-
NCT07543562
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Norway, Sweden
- Registry status
- Recruiting
Technical summary
Registry record NCT07543562. Randomized; triple masking; primary purpose treatment. Start 2026-04-01 (actual); primary completion 2030-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Selenium Intervention Registry Randomized Trial in Heart Failure
- Acronym
- SIRI-HF
- Condition
- Heart Failure
- Condition
- Heart Failure and Reduced Ejection Fraction
- Condition
- Heart Failure and Mildly Reduced Ejection Fraction
- Condition
- Heart Failure and Preserved Ejection Fraction
- Condition
- Selenium Supplementation
- Condition
- Selenium
- Condition
- Cognitive Functioning
- Intervention (Dietary supplement)
- Selenium Supplement
- Intervention (Dietary supplement)
- Placebo
- Lead sponsor
- Skane University Hospital
- Collaborator
- Uppsala University
Record details
- Record id
cardio:ct-nct07543562- Content hash
be1b5747aeadc3e40c2febc7ec4de9f19ba29f218796848b37838e1af5ee4528